Dr. Mentz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
40 Duke Medicine Cir
Durham, NC 27710Phone+1 919-684-8111Fax+1 919-620-4921
Summary
- Dr. Robert Mentz is an Associate Professor of Medicine and Chief of the Heart Failure Section at Duke University. He is the Editor-in-Chief of the Journal of Cardiac Failure – the official journal of the HFSA. He completed Internal Medicine training at Brigham and Women’s Hospital and Cardiology Fellowship at Duke University Hospital and the Duke Clinical Research Institute (DCRI). Robert spends his clinical time at Duke University Hospital assisting with the care of patients with heart failure, cardiac transplants and ventricular assist devices. He is an NIH and industry funded clinical trialist involved in ongoing trials designed to inform the care of cardiac patients. He has more than 350 peer-reviewed publications. He is an established mentor for medical students, residents and cardiology fellows and was the recipient of the 2021 Clinical Research Mentoring Award from the Duke School of Medicine and the 2017 W. Proctor Harvey Award from the ACC.
Education & Training
Duke University HospitalFellowship, Cardiovascular Disease, 2010 - 2014
Brigham and Women's HospitalResidency, Internal Medicine, 2007 - 2010
Emory University School of MedicineClass of 2007
Certifications & Licensure
NC State Medical License 2010 - 2025
MA State Medical License 2009 - 2012- American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Clinical Research Mentoring Award Duke School of Medicine, 2021
- W. Proctor Harvey Award American College of Cardiology, 2017
Clinical Trials
- TRANSFORM-HF: ToRsemide compArisoN With furoSemide FORManagement of Heart Failure Start of enrollment: 2018 Jul 11
- TRANSFORM-HF Ancillary Mechanistic Study Start of enrollment: 2020 Dec 10
- Changes in NT-proBNP, Safety, and Tolerability in HFpEF Patients With a WHF Event (HFpEF Decompensation) Who Have Been Stabilized and Initiated at the Time of or Within 30 Days Post-decompensation (PARAGLIDE-HF) Start of enrollment: 2019 Jun 27
- Join now to see all
Publications & Presentations
PubMed
- 19 citationsNatriuretic Peptides: Role in the Diagnosis and Management of Heart Failure: A Scientific Statement From the Heart Failure Association of the European Society of Cardi...Hiroyuki Tsutsui, Nancy M Albert, Andrew J S Coats, Stefan D Anker, Antoni Bayes-Genis
Journal of Cardiac Failure. 2023-05-01 - 9 citationsCardiovascular Burden of the V142I Transthyretin Variant.Senthil Selvaraj, Brian Claggett, Svati H Shah, Robert J Mentz, Michel G Khouri
JAMA. 2024-06-04 - 368 citationsThe SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial.Adriaan A Voors, Christiane E Angermann, John R Teerlink, Sean P Collins, Mikhail Kosiborod
Nature Medicine. 2022-03-01
Journal Articles
- Performance of the Pooled Cohort Equations to Estimate Atherosclerotic Cardiovascular Disease Risk by Body Mass IndexRohan Khera, Vijay Nambi, Stephen L Seliger, Monika M Safford, Robert J Mentz, Donald M Lloyd-Jones, Ian J Neeland, JAMA Network Open
- Cost-Effectiveness of Contemporary Statin Use Guidelines with or Without Coronary Artery Calcium Assessment in African American IndividualsRobert J Mentz, Venkatesh L Murthy, JAMA Cardiology
- State-of-the-Art Paper Antihyperglycemic Therapies to Treat Patients with Heart Failure and Diabetes MellitusRobert J Mentz, Javed Butler, ScienceDirect
- Join now to see all
Lectures
- Hospitalization for Heart Failure: A Bad Omen or an Opportunity?2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
- Acute Heart Failure: What Do We Know? Where Can We go?2019 ACC Scientific Session & Expo, New Orleans - 3/16/2019
- Young Investigator Awards: Clinical Investigations2019 ACC Scientific Session & Expo, New Orleans - 3/16/2019
Authored Content
- Cost-Effectiveness of Contemporary Statin Use Guidelines with or Without Coronary Artery Calcium Assessment in African American IndividualsMay 2020
- Cost-Effectiveness of Contemporary Statin Use Guidelines with or Without Coronary Artery Calcium Assessment in African American IndividualsMay 2020
- Cost-Effectiveness of Contemporary Statin Use Guidelines with or Without Coronary Artery Calcium Assessment in African American IndividualsMay 2020
Press Mentions
SUMMIT: Tirzepatide ‘Huge Win’ for HFpEF Patients with ObesityNovember 16th, 2024- Semaglutide Lowers Heart Failure Risks in Patients with Type 2 Diabetes, CKDOctober 10th, 2024
- Heart Failure Society of American Names Journal of Cardiac Failure (JCF) Co-Editors-in-ChiefSeptember 17th, 2024
- Join now to see all
Grant Support
- TRANSFORM-HFYalePresent
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
